Literature DB >> 25932135

Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.

Wei Huo1, Min Du1, Xinyan Pan1, Xiaomin Zhu1, Zhimin Li1.   

Abstract

OBJECTIVE: ALDH1 has recently been reported as a marker of cancer stem-like cells in lung cancer. However, the predictive value of ALDH1 in lung cancer remains controversial. In this study, we aimed to evaluate the association of ALDH1 expression with the clinicopathological features and outcomes of lung cancer patients through a meta-analysis.
METHODS: Publications that assessed the clinical or prognostic significance of ALDH1 in lung cancer up to October 2014 were identified. A meta-analysis was performed to clarify the association between ALDH1 expression and clinical outcomes.
RESULTS: Ten eligible publications with 1836 patients were included. The analysis of these data showed that ALDH1 expression was highly correlated with lymph node metastasis (pooled OR = 1.45, 95% CI: 1.04-2.02, P = 0.027), decreased overall survival (pooled RR: 2.25, 95% CI: 1.15-4.41, P = 0.019), and decreased disease-free survival (pooled RR: 1.63, 95% CI: 1.01-2.64, P = 0.047).
CONCLUSION: Patients with ALDH1-positive lung cancer had poor prognosis, which was associated with common clinicopathological poor prognostic factors.

Entities:  

Keywords:  Lung cancer; aldh1; cancer stem cells; outcome

Year:  2015        PMID: 25932135      PMCID: PMC4402782     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

Review 1.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

2.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

Authors:  M K Parmar; V Torri; L Stewart
Journal:  Stat Med       Date:  1998-12-30       Impact factor: 2.373

3.  Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.

Authors:  Kazuhiko Shien; Shinichi Toyooka; Kouichi Ichimura; Junichi Soh; Masashi Furukawa; Yuho Maki; Takayuki Muraoka; Norimitsu Tanaka; Tsuyoshi Ueno; Hiroaki Asano; Kazunori Tsukuda; Masaomi Yamane; Takahiro Oto; Katsuyuki Kiura; Shinichiro Miyoshi
Journal:  Lung Cancer       Date:  2012-03-03       Impact factor: 5.705

4.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

Review 5.  Human aldehyde dehydrogenase gene family.

Authors:  A Yoshida; A Rzhetsky; L C Hsu; C Chang
Journal:  Eur J Biochem       Date:  1998-02-01

6.  Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.

Authors:  Koji Okudela; Tetsukan Woo; Hideaki Mitsui; Michihiko Tajiri; Munetaka Masuda; Kenichi Ohashi
Journal:  Pathol Int       Date:  2012-12       Impact factor: 2.534

7.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

8.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

Authors:  Yu-Chih Chen; Yi-Wei Chen; Han-Shui Hsu; Ling-Ming Tseng; Pin-I Huang; Kai-Hsi Lu; Dow-Tien Chen; Lung-Kuo Tai; Ming-Chi Yung; Shih-Ching Chang; Hung-Hai Ku; Shih-Hwa Chiou; Wen-Liang Lo
Journal:  Biochem Biophys Res Commun       Date:  2009-05-18       Impact factor: 3.575

9.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

10.  Cancer stem cell subsets and their relationships.

Authors:  Hai-Guang Liu; Chong Chen; Han Yang; Yi-Fei Pan; Xiao-Hua Zhang
Journal:  J Transl Med       Date:  2011-05-04       Impact factor: 5.531

View more
  12 in total

1.  Aberrant expression of ALDH1, MMP9, Integrin αvβ3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.

Authors:  Xicheng Yue; Zhengquan Han; Ligong Zhang; Jing Li; Xiaomeng Gong
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.

Authors:  Zhengqi Bao; Zenong Cheng; Damin Chai
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

3.  The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.

Authors:  Maria A Voronkova; Liying W Rojanasakul; Chayanin Kiratipaiboon; Yon Rojanasakul
Journal:  Mol Cell Biol       Date:  2020-01-03       Impact factor: 4.272

4.  Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.

Authors:  Hejing Wang; Yanmeng Li; Donghu Zhou; Xiaojin Li; Siyu Jia; Saiping Qi; Jian Huang
Journal:  Histol Histopathol       Date:  2021-01-13       Impact factor: 2.303

5.  The prognostic roles of ALDH1 isoenzymes in gastric cancer.

Authors:  Kai Li; Xiaoguang Guo; Ziwei Wang; Xiaofeng Li; Youquan Bu; Xuefeng Bai; Liansheng Zheng; Ying Huang
Journal:  Onco Targets Ther       Date:  2016-06-07       Impact factor: 4.147

6.  Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.

Authors:  Lan Yu; Bo Zhu; Shiwu Wu; Lei Zhou; Wenqing Song; Xiaomeng Gong; Danna Wang
Journal:  Diagn Pathol       Date:  2017-03-02       Impact factor: 2.644

7.  NRP1-positive lung cancer cells possess tumor-initiating properties.

Authors:  Luis E Jimenez-Hernandez; Karla Vazquez-Santillan; Rosario Castro-Oropeza; Gustavo Martinez-Ruiz; Laura Muñoz-Galindo; Carolina Gonzalez-Torres; Carlo C Cortes-Gonzalez; Georgina Victoria-Acosta; Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Oncol Rep       Date:  2017-11-09       Impact factor: 3.906

Review 8.  Drug Resistance Driven by Cancer Stem Cells and Their Niche.

Authors:  Marta Prieto-Vila; Ryou-U Takahashi; Wataru Usuba; Isaku Kohama; Takahiro Ochiya
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

9.  Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.

Authors:  Bo Zhu; Lei Zhou; Lan Yu; Shiwu Wu; Wenqing Song; Xiaomeng Gong; Danna Wang
Journal:  BMC Surg       Date:  2017-04-21       Impact factor: 2.102

Review 10.  Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.

Authors:  Kha-Liang Lee; Yung-Che Kuo; Yuan-Soon Ho; Yen-Hua Huang
Journal:  Cancers (Basel)       Date:  2019-09-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.